000153596 001__ 153596
000153596 005__ 20240229123045.0
000153596 0247_ $$2doi$$a10.1007/s11864-020-0707-5
000153596 0247_ $$2pmid$$apmid:32025928
000153596 0247_ $$2ISSN$$a1527-2729
000153596 0247_ $$2ISSN$$a1534-6277
000153596 0247_ $$2altmetric$$aaltmetric:75330815
000153596 037__ $$aDKFZ-2020-00340
000153596 041__ $$aeng
000153596 082__ $$a610
000153596 1001_ $$0P:(DE-He78)24fe6057396bec79d2638615b12eb989$$aThong, Melissa$$b0$$eFirst author$$udkfz
000153596 245__ $$aCancer-Related Fatigue: Causes and Current Treatment Options.
000153596 260__ $$aPhiladelphia, Pa.$$bCurrent Science$$c2020
000153596 3367_ $$2DRIVER$$aarticle
000153596 3367_ $$2DataCite$$aOutput Types/Journal article
000153596 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1636021828_31474$$xReview Article
000153596 3367_ $$2BibTeX$$aARTICLE
000153596 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000153596 3367_ $$00$$2EndNote$$aJournal Article
000153596 500__ $$a#EA:C071#LA:C071#
000153596 520__ $$aCancer-related fatigue (CRF) is a problem for a significant proportion of cancer survivors during and after active cancer treatment. However, CRF is underdiagnosed and undertreated. Interventions are available for CRF although there is no gold standard. Based on current level of evidence, exercise seems to be most effective in preventing or ameliorating CRF during the active- and posttreatment phases.
000153596 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000153596 588__ $$aDataset connected to CrossRef, PubMed,
000153596 7001_ $$00000-0002-6191-0505$$avan Noorden, Cornelis J F$$b1
000153596 7001_ $$0P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aSteindorf, Karen$$b2$$udkfz
000153596 7001_ $$0P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0$$aArndt, Volker$$b3$$eLast author$$udkfz
000153596 773__ $$0PERI:(DE-600)2090563-4$$a10.1007/s11864-020-0707-5$$gVol. 21, no. 2, p. 17$$n2$$p17$$tCurrent treatment options in oncology$$v21$$x1534-6277$$y2020
000153596 909CO $$ooai:inrepo02.dkfz.de:153596$$pVDB
000153596 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)24fe6057396bec79d2638615b12eb989$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000153596 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000153596 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000153596 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000153596 9141_ $$y2020
000153596 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCURR TREAT OPTION ON : 2017
000153596 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000153596 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000153596 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000153596 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000153596 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000153596 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000153596 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000153596 9202_ $$0I:(DE-He78)C071-20160331$$kC071$$lC071 Cancer Survivorship$$x1
000153596 9201_ $$0I:(DE-He78)C071-20160331$$kC071$$lC071 Cancer Survivorship$$x0
000153596 9201_ $$0I:(DE-He78)C110-20160331$$kC110$$lBewegung, Präventionsforschung und Krebs$$x1
000153596 9200_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x1
000153596 980__ $$ajournal
000153596 980__ $$aVDB
000153596 980__ $$aI:(DE-He78)C071-20160331
000153596 980__ $$aI:(DE-He78)C110-20160331
000153596 980__ $$aUNRESTRICTED